SAM #36C24626Q0972

Sole Source Procurement of Phadia 250 Reagents and Consumables for Fayetteville VAMC

This opportunity is a sole source procurement for reagents and consumables used with the Phadia 250 instrument at the Fayetteville VA Medical Center. - Agency: Department of Veterans Affairs, Network Contracting Office (NCO) 6 - Location: Fayetteville VA Medical Center - Requirement: Reagents and consumables for the Phadia 250 instrument - The Phadia 250 instrument is already owned by the medical center - OEM: Thermo Fisher Scientific (via Fisher Scientific Company LLC) - Contract Type: Sole source, firm fixed price - Reason: Only Fisher Scientific is authorized to supply these items; alternatives would cause unacceptable duplication of cost or delay in patient care - Commercial Opportunity: Other vendors may respond if they can demonstrate capability to supply equivalent reagents and consumables - No specific part numbers or quantities provided in the notice - Details may be available in referenced attachments

Key Points: - Sole source procurement for specialized medical laboratory supplies - Focused on Phadia 250 instrument reagents and consumables - Thermo Fisher Scientific is the only authorized manufacturer - Opportunity for other vendors to respond if they can meet requirements

Description

The Department of Veterans Affairs, Network Contracting Office (NCO) 6 intends to award a sole source, firm fixed price contract to Fisher Scientific Company LLC (LB), 11450 Compaq Center West Dr St., Houston, TX, 77070 for the Phadia 250 associated reagents and consumables for the Fayetteville VAMC located at 2300 Ramsey Street, Fayetteville, NC, 28301. The Phadia 250 instrument is currently owned by the Fayetteville VAMC and Fisher Scientific Company LLC (LB) a branch Thermo Fisher Scientific (LB) (OEM) is the sole authorized source for the procurement of the Phadia 250 instrument and its associated reagents and consumables. Market research has determined that these items can only be obtained from a single source without an unacceptable duplication of cost or delay in the continuity of patient care. No solicitation documents are available, and telephone requests will not be accepted.

However, any business that believes it can provide the Phadia 250 reagents and consumables may give written notice to Cherisse.Hall@va.gov by 12:00pm EDT on 9/4/2026. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirement. Interested and capable respondents are requested to provide the information below.

All responses to this notice shall include company name, address, point of contact, phone number, System for Award (SAMs) Unique Entity Id Number (UEI), capabilities statement, and past performance.

Responses will be considered by the Government; however, a determination by the Government not to compete the proposed acquisition based upon responses of this notice is solely within the discretion of the Government.

NAICS Code: 325413 In Vitro Diagnostic Substance Manufacturing

PSC: 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

View original listing